Lupin Limited
LUPIN
Pozycja w akcjach
#2110
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
Cena akcji
$21.40
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$9.79B
Zmiana (1 dzień)
-1.36%
Zmiana (1 rok)
-3.25%
Kraj
IN
Handel Lupin Limited (LUPIN)
Kategoria
Healthcare
Marża operacyjna dla Lupin Limited (LUPIN)
Marża operacyjna na dzień October 2026 TTM: 25.22%
Według najnowszych raportów finansowych i ceny akcji Lupin Limited, bieżąca marża operacyjna (TTM) wynosi 25.22%. Na koniec 2024 wynosiła 38.88%.
Historia marży operacyjnej dla Lupin Limited od 2004 do 2026
Marża operacyjna na koniec każdego roku
| Rok | Marża operacyjna | Zmień |
|---|---|---|
| 2026 (TTM) | 25.22% | -39.59% |
| 2025 | 41.75% | 7.38% |
| 2024 | 38.88% | 671.43% |
| 2023 | 5.04% | -36.04% |
| 2022 | 7.88% | -30.94% |
| 2021 | 11.41% | 26.08% |
| 2020 | 9.05% | -24.46% |
| 2019 | 11.98% | -9.99% |
| 2018 | 13.31% | -41.73% |
| 2017 | 22.84% | -3.26% |
| 2016 | 23.61% | -10.74% |
| 2015 | 26.45% | 3.77% |
| 2014 | 25.49% | 22.08% |
| 2013 | 20.88% | 18.97% |
| 2012 | 17.55% | -2.66% |
| 2011 | 18.03% | -1.53% |
| 2010 | 18.31% | 5.41% |
| 2009 | 17.37% | -18.60% |
| 2008 | 21.34% | -3.35% |
| 2007 | 22.08% | 45.74% |
| 2006 | 15.15% | 55.07% |
| 2005 | 9.77% | -51.27% |
| 2004 | 20.05% | 0.00% |
Marża operacyjna dla podobnych firm lub konkurentów
| Firma | Marża operacyjna | Różnica w marży operacyjnej | Kraj |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -99.09% |
IN
|
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.